ES2118726T3 - Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos. - Google Patents
Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos.Info
- Publication number
- ES2118726T3 ES2118726T3 ES91106438T ES91106438T ES2118726T3 ES 2118726 T3 ES2118726 T3 ES 2118726T3 ES 91106438 T ES91106438 T ES 91106438T ES 91106438 T ES91106438 T ES 91106438T ES 2118726 T3 ES2118726 T3 ES 2118726T3
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- growth factor
- neurons
- medication
- restoration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000015122 neurodegenerative disease Diseases 0.000 title abstract 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 title 1
- 101800003838 Epidermal growth factor Proteins 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940116977 epidermal growth factor Drugs 0.000 title 1
- 210000002569 neuron Anatomy 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003102 growth factor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE DESCRIBEN COMPOSICIONES FARMACEUTICAS QUE CONTIENEN FACTOR DE CRECIMIENTO EPIDERMICO (EGF) COMO INGREDIENTE ACTIVO Y SU USO EN EL TRATAMIENTO DE TRASTORNOS NEURODEGENERATIVOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT20144A IT1240683B (it) | 1990-04-26 | 1990-04-26 | Composizione farmaceutica contenente egf |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2118726T3 true ES2118726T3 (es) | 1998-10-01 |
Family
ID=11164158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES91106438T Expired - Lifetime ES2118726T3 (es) | 1990-04-26 | 1991-04-22 | Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos. |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US5200396A (es) |
| EP (1) | EP0454026B1 (es) |
| AT (1) | ATE167060T1 (es) |
| DE (1) | DE69129563T2 (es) |
| ES (1) | ES2118726T3 (es) |
| IT (1) | IT1240683B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4237047A1 (en) * | 1991-11-04 | 1993-05-06 | I N R O Handels-Gmbh, 8750 Aschaffenburg, De | Drug contg. polypeptide homologous to nerve growth factor and slow virus sequence - for treating amyotrophic lateral sclerosis, spinal muscle atrophy or Parkinson's disease |
| FR2684301B1 (fr) * | 1991-12-02 | 1995-03-24 | Synthelabo | Composition pharmaceutique contenant de l'egf pour le traitement des pathologies bronchopulmonaires. |
| WO1994009371A1 (en) * | 1992-10-09 | 1994-04-28 | Massachusetts Institute Of Technology | Antemortem diagnostic test for alzheimer's disease |
| DK0728194T3 (da) * | 1993-11-09 | 2003-04-22 | Neurospheres Holdings Ltd | In situ modifikation og manipulation af stamceller fra centralnervesystemet. |
| EP0743066A3 (en) * | 1995-05-16 | 1998-09-30 | Mitsui Pharmaceuticals, Inc. | Wound-healing agent |
| CA2450127A1 (en) * | 2001-06-14 | 2002-12-27 | Shujian Wu | Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, bgs-8, expressed highly in immune tissue |
| WO2004005520A1 (en) * | 2002-07-03 | 2004-01-15 | Nexgen Biotechnologies, Inc. | Method for preparing fusion polypeptide comprising epidermal growth factor and human serum albumin in plants |
| ES2304818B1 (es) | 2005-05-23 | 2009-10-26 | Universidad Del Pais Vasco | Metodos para el diagnostico y pronostico de las enfermedades desmielinizantes y para el desarrollo de medicamentos contra las enfermedades desmielinizantes. |
| CN101897953B (zh) * | 2009-05-27 | 2013-03-27 | 中国人民解放军军事医学科学院毒物药物研究所 | 无创性高穿透性表皮生长因子及其应用 |
| WO2013166487A1 (en) | 2012-05-04 | 2013-11-07 | Yale University | Highly penetrative nanocarriers for treatment of cns disease |
| CN103204920A (zh) * | 2013-04-28 | 2013-07-17 | 中国人民解放军军事医学科学院毒物药物研究所 | 一种新型表皮生长因子及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE38892B1 (en) * | 1973-03-28 | 1978-06-21 | Ici Ltd | Pharmaceutical compositions |
| DE3585618D1 (de) * | 1984-10-19 | 1992-04-16 | Chiron Corp | Anregung zur heilung einer wunde mittels menschlichen hautwachstumsfaktors hergestellt durch rekombinant-dns. |
| NZ235556A (en) * | 1986-11-05 | 1991-06-25 | Ethicon Inc | Breast milk substitute containing recombinant human egf |
| CA1322714C (en) * | 1986-11-14 | 1993-10-05 | Harry N. Antoniades | Wound healing and bone regeneration |
| US5057494A (en) * | 1988-08-03 | 1991-10-15 | Ethicon, Inc. | Method for preventing tissue damage after an ischemic episode |
| US5036046A (en) * | 1988-10-12 | 1991-07-30 | Eye Research Institute Of Retina Foundation, Inc. | Method for enhancing healing of corneal endothelial wounds |
| WO1990011781A1 (en) * | 1989-04-04 | 1990-10-18 | Alcon Laboratories, Inc. | The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions |
| JP3187410B2 (ja) * | 1989-08-10 | 2001-07-11 | 住友製薬株式会社 | 脳内投与用徐放性製剤 |
-
1990
- 1990-04-26 IT IT20144A patent/IT1240683B/it active IP Right Grant
-
1991
- 1991-04-22 DE DE69129563T patent/DE69129563T2/de not_active Expired - Fee Related
- 1991-04-22 EP EP91106438A patent/EP0454026B1/en not_active Expired - Lifetime
- 1991-04-22 ES ES91106438T patent/ES2118726T3/es not_active Expired - Lifetime
- 1991-04-22 AT AT91106438T patent/ATE167060T1/de not_active IP Right Cessation
- 1991-04-24 US US07/690,670 patent/US5200396A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69129563T2 (de) | 1999-01-07 |
| EP0454026A1 (en) | 1991-10-30 |
| IT9020144A1 (it) | 1991-10-26 |
| US5200396A (en) | 1993-04-06 |
| IT1240683B (it) | 1993-12-17 |
| EP0454026B1 (en) | 1998-06-10 |
| DE69129563D1 (de) | 1998-07-16 |
| ATE167060T1 (de) | 1998-06-15 |
| IT9020144A0 (it) | 1990-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE157251T1 (de) | Verwendung von inositoltriphosphat zur behandlung von entzündungen | |
| ES2058151T3 (es) | Complejos de saponinas con fosfolipidos y composiciones farmaceuticas y cosmeticas que los contienen. | |
| ATE33503T1 (de) | Pharmazeutische und tiermedizinische praeparate von interleukin-2, in dem cystein-125 ausgetauscht worden ist (muteine), sowie deren herstellung. | |
| ATE248597T1 (de) | Acyclovirhaltige antiherpesarzneistift zur topischen anwendung | |
| ES2002089T3 (es) | Nuevas formulaciones farmaceuticas con liberacion programada que contienen antiflogisticos. | |
| PT693924E (pt) | Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos | |
| MX9304710A (es) | Composicion farmaceutica y/o cosmetica y su uso. | |
| DE59007178D1 (de) | Verwendung alkylierter Polyethylenimine als gallensäureadsorbierende Arzneimittel sowie pharmazeutische Präparate. | |
| ES2052603T3 (es) | Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen. | |
| DE69521693T2 (de) | Taxanderivate enthaltende arzneizubereitungen | |
| ES2118726T3 (es) | Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos. | |
| ES2034926T1 (es) | Composiciones farmaceuticas orales liquidas con actividad anti-inflamatoria. | |
| IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
| ES2089687T3 (es) | 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa. | |
| DE69322251D1 (de) | Medizinische zusammensetzung | |
| DK0443224T3 (da) | Anvendelse af thrombospondin til fremskyndelse af sårheling | |
| DE60031016D1 (de) | Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen | |
| GR1001511B (el) | Στεροειδείς συν?έσεις. | |
| ATE38151T1 (de) | Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung. | |
| ES2059312T3 (es) | Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion. | |
| ES2124861T3 (es) | Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa. | |
| DE69927260D1 (de) | Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis | |
| ES2053679T3 (es) | Embonato de azelastina, procedimiento para su preparacion y preparados farmaceuticos que contienen embonato de azelastina como principio activo. | |
| DE59205998D1 (de) | Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung | |
| FR2392674A1 (fr) | Compositions pharmaceutiques a base d'elastine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 454026 Country of ref document: ES |